Targeting ion channels for the treatment of gastrointestinal motility disorders

Arthur Beyder1, Gianrico Farrugia

  • 1Enteric Neuroscience Program, Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.

Insights

Gastrointestinal motility disorders affect many people, but treatments are challenging. This review explores voltage-sensitive ion channels (VSICs) in smooth muscle cells and interstitial cells of Cajal as potential therapeutic targets.

Area of Science:

  • Gastroenterology
  • Molecular Biology
  • Physiology

Background:

  • Gastrointestinal (GI) functional and motility disorders are common, causing significant morbidity.
  • Diagnosis and treatment are challenging due to complex pathophysiology involving nervous systems and GI wall.
  • Interstitial cells of Cajal (ICCs) and smooth muscle cells (SMCs) generate electrical activity via voltage-sensitive ion channels (VSICs).

Purpose of the Study:

  • To review the role of VSICs in GI motility.
  • To discuss the molecular mechanisms of VSICs in ICCs and SMCs.
  • To explore targeting VSICs for therapeutic interventions in GI motility disorders.

Main Methods:

  • Review of literature on VSICs in GI physiology.
  • Analysis of molecular and structural biology data.
  • Electrophysiological studies of ICCs and SMCs.

Main Results:

  • VSICs, including Na(V), Ca(V), K(V), K(Ca), Cl(-), and TRP channels, are crucial for GI electrical activity.
  • These channels exhibit structural homology and common functional mechanisms.
  • Targeting specific sites on VSICs offers potential for drug development.

Conclusions:

  • VSICs are key regulators of GI electrical activity and motility.
  • Understanding VSIC structure and function is vital for developing new therapies.
  • Targeting VSICs presents a promising strategy for managing GI motility disorders.

Related Concept Videos

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...